These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Appraisal of therapeutic agents for peptic ulcer by continuous intragastric pH monitoring]. Saeki S, Tomofuji Y, Yasuda T, Mitooka H, Onoyama Y, Baba S. Rinsho Byori; 1984 Oct; 32(10):1076-83. PubMed ID: 6549190 [No Abstract] [Full Text] [Related]
3. [Protein composition and pepsin of the gastric juice in patients with peptic ulcer during treatment]. Degtiareva II, Svistun TI, Zagorodneva AG. Klin Med (Mosk); 1983 Aug; 61(8):48-55. PubMed ID: 6417401 [No Abstract] [Full Text] [Related]
7. [Comparative study of treatment with the classical method and with Ulcosilvanil in gastroduodenal ulcer]. Dumitrasçu D, Acalovschi M, Andreica V, Badea G, Drăghici A, Georoceanu A, Grănescu S, Lencu M, Marin M, Pascu O. Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1985 Aug; 37(6):529-40. PubMed ID: 2871611 [No Abstract] [Full Text] [Related]
13. [The effect of atropine-N-n-octylbromide on the actual acidity of the stomach. Studies on the therapy of peptic ulcer]. Gromotka R, Fahsold W. Arzneimittelforschung; 1966 Jun; 16(6):766-8. PubMed ID: 6014590 [No Abstract] [Full Text] [Related]
14. Addition of a H2 receptor antagonist to PPI improves acid control and decreases nocturnal acid breakthrough. Mainie I, Tutuian R, Castell DO. J Clin Gastroenterol; 2008 Jul; 42(6):676-9. PubMed ID: 18496394 [Abstract] [Full Text] [Related]